Cure My Disease

Don't miss your cure!

 Log in / Sign up

Extended trial tests new cholesterol fighter

NCT ID NCT05413135

Completed Disease control Sponsor: Arrowhead Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study followed adults with high cholesterol who had already completed a previous trial of the experimental drug ARO-APOC3. Participants continued receiving the medication every 3-6 months to evaluate its long-term safety and effectiveness at controlling cholesterol levels. The research aimed to understand how well the treatment works over an extended period and monitor for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clincal Research Site 4

    Boca Raton, Florida, 33434, United States

  • Clinical Research Site 1

    Beverly Hills, California, 90211, United States

  • Clinical Research Site 10

    Pembroke Pines, Florida, 33024, United States

  • Clinical Research Site 11

    Port Orange, Florida, 32127, United States

  • Clinical Research Site 12

    Dunwoody, Georgia, 30338, United States

  • Clinical Research Site 13

    Minneapolis, Minnesota, 55455, United States

  • Clinical Research Site 14

    Tupelo, Mississippi, 38801, United States

  • Clinical Research Site 15

    Omaha, Nebraska, 68114, United States

  • Clinical Research Site 16

    Las Vegas, Nevada, 89121, United States

  • Clinical Research Site 17

    Long Island City, New York, 11106, United States

  • Clinical Research Site 18

    New Windsor, New York, 12553, United States

  • Clinical Research Site 19

    New York, New York, 10029, United States

  • Clinical Research Site 2

    Northridge, California, 91325, United States

  • Clinical Research Site 20

    Morehead City, North Carolina, 28557, United States

  • Clinical Research Site 21

    Fargo, North Dakota, 58104, United States

  • Clinical Research Site 22

    Marion, Ohio, 43302, United States

  • Clinical Research Site 23

    Maumee, Ohio, 43537, United States

  • Clinical Research Site 24

    Oklahoma City, Oklahoma, 73135, United States

  • Clinical Research Site 25

    Greenville, South Carolina, 29607, United States

  • Clinical Research Site 26

    Chattanooga, Tennessee, 37421, United States

  • Clinical Research Site 27

    Houston, Texas, 77030, United States

  • Clinical Research Site 28

    Houston, Texas, 77099, United States

  • Clinical Research Site 29

    Houston, Texas, 77002, United States

  • Clinical Research Site 3

    Palm Springs, California, 92292, United States

  • Clinical Research Site 30

    San Antonio, Texas, 78249, United States

  • Clinical Research Site 31

    Manassas, Virginia, 20110, United States

  • Clinical Research Site 32

    Camperdown, New South Wales, 2050, Australia

  • Clinical Research Site 33

    Milton, Queensland, 4068, Australia

  • Clinical Research Site 34

    Sippy Downs, Queensland, 4556, Australia

  • Clinical Research Site 35

    Adelaide, South Australia, 5000, Australia

  • Clinical Research Site 36

    Clayton, Victoria, 3168, Australia

  • Clinical Research Site 37

    Joondalup, Washington, 6027, Australia

  • Clinical Research Site 38

    Nedlands, Washington, 6009, Australia

  • Clinical Research Site 39

    Concord, Ontario, L4K4M2, Canada

  • Clinical Research Site 40

    London, Ontario, N6A 5A5, Canada

  • Clinical Research Site 41

    Chicoutimi, Quebec, G7H 7K9, Canada

  • Clinical Research Site 43

    Montreal, Quebec, H2W 1R7, Canada

  • Clinical Research Site 44

    Québec, Quebec, G1G 3Z4, Canada

  • Clinical Research Site 46

    Balatonfüred, H-8230, Hungary

  • Clinical Research Site 47

    Békéscsaba, 5600, Hungary

  • Clinical Research Site 48

    Debrecen, 4032, Hungary

  • Clinical Research Site 49

    Gyöngyös, 3200, Hungary

  • Clinical Research Site 5

    Fort Lauderdale, Florida, 33308, United States

  • Clinical Research Site 50

    Komárom, H-2900, Hungary

  • Clinical Research Site 51

    Nyíregyháza, 4400, Hungary

  • Clinical Research Site 53

    Amsterdam, 1105 AZ, Netherlands

  • Clinical Research Site 54

    Sneek, 8601 ZR, Netherlands

  • Clinical Research Site 55

    Zwijndrecht, 3331LZ, Netherlands

  • Clinical Research Site 56

    Christchurch, 8011, New Zealand

  • Clinical Research Site 57

    Christchurch, 8013, New Zealand

  • Clinical Research Site 58

    Papatoetoe, Aukland, 2025, New Zealand

  • Clinical Research Site 59

    Bydgoszcz, 85-605, Poland

  • Clinical Research Site 6

    Miami, Florida, 33173, United States

  • Clinical Research Site 60

    Oświęcim, 32-600, Poland

  • Clinical Research Site 61

    Poznan, 61-655, Poland

  • Clinical Research Site 62

    Rzeszów, 35-055, Poland

  • Clinical Research Site 63

    Lodz, 94 046, Poland

  • Clinical Research Site 64

    Lodz, 93-338, Poland

  • Clinical Research Site 8

    Miami, Florida, 33155, United States

  • Clinical Research Site 9

    Miami Springs, Florida, 33166, United States

Conditions

Explore the condition pages connected to this study.

DYSLIPIDEMIAS